The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant chemotherapy versus chemoradiation prior to esophagectomy: Impact on rate of complete pathologic response and survival in esophageal cancer patients.
 
Albert C. Lockhart
Research Funding - Amgen (Inst); Bayer (Inst); CTI (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Lilly (Inst); Millennium (Inst); Novartis (Inst); Regeneron (Inst); Sanofi (Inst); Teva (Inst); Vertex (Inst); Zenyaku Kogyo (Inst)
 
Pamela Parker Samson
No Relationships to Disclose
 
Cliff Grant Robinson
Stock and Other Ownership Interests - Radialogica
Consulting or Advisory Role - Radialogica
Speakers' Bureau - Varian Medical Systems; ViewRay
Research Funding - Varian Medical Systems
Travel, Accommodations, Expenses - Varian Medical Systems; ViewRay
 
Jeffrey D. Bradley
Speakers' Bureau - ViewRay
Research Funding - Varian Medical Systems
 
Varun Puri
No Relationships to Disclose
 
Stephen R. Broderick
No Relationships to Disclose
 
G Alexander Patterson
No Relationships to Disclose
 
Bryan F Meyers
Consulting or Advisory Role - Covidien; Ethicon; Varian Medical Systems
Research Funding - Ethicon
 
Traves Crabtree
Honoraria - Ethicon
Consulting or Advisory Role - Ethicon
Research Funding - Ethicon; Varian Medical Systems